Works matching AU Cattaneo, Daniele
Results: 66
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 475, doi. 10.1007/s40261-018-0623-7
- By:
- Publication type:
- Article
Essential Thrombocythemia: The Dermatologic Point of View.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2787, doi. 10.1007/s00277-024-05801-0
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1409, doi. 10.1007/s00277-023-05217-2
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 515, doi. 10.3390/jcm10030515
- By:
- Publication type:
- Article
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3692, doi. 10.3390/jcm9113692
- By:
- Publication type:
- Article
Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
- Published in:
- Histopathology, 2017, v. 71, n. 6, p. 897, doi. 10.1111/his.13309
- By:
- Publication type:
- Article
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 2963, doi. 10.2147/PPA.S369326
- By:
- Publication type:
- Article
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.750346
- By:
- Publication type:
- Article
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 12, p. 1720, doi. 10.1007/s11864-023-01149-1
- By:
- Publication type:
- Article
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs.
- Published in:
- Current Treatment Options in Oncology, 2023, v. 24, n. 7, p. 802, doi. 10.1007/s11864-023-01099-8
- By:
- Publication type:
- Article
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 267, doi. 10.1111/bjh.14553
- By:
- Publication type:
- Article
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 6, p. 890, doi. 10.1111/bjh.13343
- By:
- Publication type:
- Article
Lymphomatoid papulosis associated with myeloid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement: Successful imatinib treatment in two cases.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. 1330, doi. 10.1111/1346-8138.16836
- By:
- Publication type:
- Article
Treatment‐free remission as a new goal in the management of chronic myeloid leukemia: Clinical and biological aspects.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3309
- By:
- Publication type:
- Article
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 123, doi. 10.1002/hon.2808
- By:
- Publication type:
- Article
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Oxidative status in treatment-naïve essential thrombocythemia: a pilot study in a single center.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01441-w
- By:
- Publication type:
- Article
Trade unions and employers associations: a new welfare model.
- Published in:
- Sociologia del Lavoro, 2017, v. 2017, n. 146, p. 220, doi. 10.3280/SL2017-147012
- By:
- Publication type:
- Article
Case report: Pleural effusion during tyrosine-kinase inhibitor treatment in chronic myeloid leukemia: Not only a dasatinib-related adverse event.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1012268
- By:
- Publication type:
- Article
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2657, doi. 10.1002/cncr.33541
- By:
- Publication type:
- Article
Residual Peripheral Blood CD26<sup>+</sup> Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00194
- By:
- Publication type:
- Article
Reply to: Can circulating CD34+ cells count be used for the prognosis of myelofibrosis? Probably yes, at least in patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 6, p. e53, doi. 10.1111/bjh.18641
- By:
- Publication type:
- Article
Trend of circulating CD34<sup>+</sup> cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 3, p. 315, doi. 10.1111/bjh.18526
- By:
- Publication type:
- Article
Low‐dose ponatinib is a good option in chronic myeloid leukemia patients intolerant to previous TKIs.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E260, doi. 10.1002/ajh.25908
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E283, doi. 10.1002/ajh.25596
- By:
- Publication type:
- Article
Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. E48, doi. 10.1002/ajh.24657
- By:
- Publication type:
- Article
Early detection of pulmonary hypertension in primary myelofibrosis: The role of echocardiography, cardiopulmonary exercise testing, and biomarkers.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. E47, doi. 10.1002/ajh.24656
- By:
- Publication type:
- Article
Anagrelide and Mutational Status in Essential Thrombocythemia.
- Published in:
- BioDrugs, 2016, v. 30, n. 3, p. 219, doi. 10.1007/s40259-016-0170-9
- By:
- Publication type:
- Article
Management of Myelofibrosis: from Diagnosis to New Target Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5805, doi. 10.3390/ijms21165805
- By:
- Publication type:
- Article
Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 8, p. 1839, doi. 10.3390/ijms20081839
- By:
- Publication type:
- Article
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2023.1324258
- By:
- Publication type:
- Article
'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 6, p. 340, doi. 10.1159/000497246
- By:
- Publication type:
- Article
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.839915
- By:
- Publication type:
- Article